Asif Hossain

发表

Detection of redundant fusion transcripts as biomarkers or disease-specific therapeutic targets in breast cancer.

Krishna R. Kalari, Jennifer M. Carr, G. Schroth, 2012, Cancer research.

VCF-Miner: GUI-based application for mining variants and annotations stored in VCF files

Steven N. Hart, Jean-Pierre A. Kocher, Patrick H. Duffy, 2015, Briefings Bioinform..

Deep Sequence Analysis of Non-Small Cell Lung Cancer: Integrated Analysis of Gene Expression, Alternative Splicing, and Single Nucleotide Variations in Lung Adenocarcinomas with and without Oncogenic KRAS Mutations

Krishna R. Kalari, Jennifer M. Carr, Asha A. Nair, 2012, Front. Oncol..

Epidaurus: aggregation and integration analysis of prostate cancer epigenome

Asif Hossain, J. Kocher, Liguo Wang, 2014, Nucleic acids research.

A novel bioinformatics pipeline for identification and characterization of fusion transcripts in breast cancer and normal cell lines

Krishna R. Kalari, G. Schroth, Y. Asmann, 2011, Nucleic acids research.

Disease-Specific Therapeutic Targets in Breast Cancer Detection of Redundant Fusion Transcripts as Biomarkers or

Krishna R. Kalari, Jennifer M. Carr, G. Schroth, 2012 .

Comprehensive Assessment of Potential Multiple Myeloma Immunoglobulin Heavy Chain V-D-J Intraclonal Variation Using Massively Parallel Pyrosequencing

Y. Asmann, Asif Hossain, A. Dispenzieri, 2012, Oncotarget.

The Biological Reference Repository (BioR): a rapid and flexible system for genomics annotation

Steven N. Hart, Jean-Pierre A. Kocher, Patrick H. Duffy, 2014, Bioinform..

TREAT: a bioinformatics tool for variant annotations and visualizations in targeted and exome sequencing data

Ying Li, Saurabh Baheti, Eric W. Klee, 2011, Bioinform..

Molecular Modeling and Functional Analysis of Exome Sequencing–Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma

Gavin R. Oliver, Jennifer B. McCormick, Tammy M. McAllister, 2019 .

Molecular Modeling and Functional Analysis of Exome Sequencing–Derived Variants of Unknown Significance Identify a Novel, Constitutively Active FGFR2 Mutant in Cholangiocarcinoma

Gavin R. Oliver, Jennifer B. McCormick, Tammy M. McAllister, 2017, JCO precision oncology.